Firm Client Monsanto Takes Step Forward in 11th Circuit Preemption Appeal
- Toxic Torts & Products Liability
- July 10, 2023
Eric Lasker is prized by clients and colleagues for his ability to quickly get to the heart of complex legal matters. He has demonstrated an extraordinary ability to collect, identify and distill vast amounts of technical information into strategic priorities and key substantive themes around which to develop and implement sophisticated medical causation and science-based defenses. Mission-focused and a quick study, Eric is seasoned in all stages of litigation and is often hired by clients for his devotion to their broader business and legal interests, as much as for the technical experience he brings to the case.
Recognized by Law360 as a Product Liability MVP, Eric litigates a wide variety of complex civil matters with a focus on toxic torts, environmental litigation, and pharmaceutical products liability. He has successfully litigated bet-the-company disputes involving Daubert challenges, the federal preemption defense, and environmental natural resource damages claims. Eric has represented his clients’ interests as lead counsel in multi-district litigation, mass torts, jury trials and bench proceedings, and in oral argument in multiple federal courts of appeal and state supreme courts. He represents clients in matters arising both in the United States and abroad, under both domestic and international law, in matters involving sensitive national security issues, and in meetings with both U.S. and foreign government officials.
Eric’s prowess in high-stakes litigation matters was heralded by The American Lawyer in identifying him as “Litigator of the Week.” He also was featured on the Bloomberg News program “Rainmakers” for his work securing a complete victory for firm client, DynCorp International, in defense of its work as a contractor to the U.S. Department of State in support of the joint United States-Colombia war-on-drugs initiative known as “Plan Colombia.”
With significant experience defending against all matter of legal claims involving FDA-regulated and EPA-regulated products and alleged toxins and environmental contaminants, Eric has represented clients in toxics/environmental matters involving herbicides, asbestos, lead, nonionizing radiation, arsenic, and chemical solvents, and in pharmaceutical products liability claims involving:
He assists clients in due diligence investigations that relate to environmental and toxics liabilities, in product stewardship efforts, and through an active amicus practice on behalf of various industry organizations. Eric also played a prominent role in helping to establish asbestos defendants’ rights to insurance non-products coverage that secured one of the seminal judicial opinions recognizing the existence of such coverage, litigation efforts that resulted in securing several hundreds of millions of dollars in asbestos non-products insurance recoveries.
Known for his skilled writing, Eric has been the recipient of the George Yancey Memorial Award and the Burton Award for excellence in legal writing and is often requested to speak and publish on issues of interest to his clients. He is co-author of Defending Daubert: It’s Time to Amend Federal Rule of Evidence 702, which triggered the FRE Advisory Committee’s consideration of potential amendments to FRE 702. In 2018, Eric participated in a roundtable discussion on the potential amendment sponsored by the Judicial Conference Advisory Committee on Rules of Evidence. In 2022, he testified before the Committee again in support of the proposed amendment, which was then unanimously approved by the Committee on Rules of Practice and Procedure and which will go into effect December 1, 2023.
Hollingsworth LLP represents Monsanto in In Re:Roundup Products Liability Litigation in the Northern District of California.
These AV® Preeminent™ rated attorneys named in October 2016 as legal industry leaders.
The Firm and the U.S. Chamber of Commerce filed a business coalition amici curiae brief supporting the mobile phone industry.
Firm files industry coalition amicus brief urging the U.S. Supreme Court to grant certiorari in Gibson v. American Cyanamid.
Partner Eric Lasker's blog post on Washington Legal Foundation's The Legal Pulse
Partner Eric G. Lasker discusses the present state of asbestos litigation in Texas and what could loom on the horizon since the Texas Supreme Court granted review in Bostic v. Georgia-Pacific Corp.
Each year at the International Association of Defense Counsel annual meeting, the award is bestowed on the author or authors of the best article published in Defense Counsel Journal during the preceding year.
The DynCorp ruling is a welcome and much needed rebuke to international activist efforts to demonize U.S. industry through unfounded legal actions arising from international operations.
The American Lawyer journal highlights DynCorp's success as counter to Chevron's legal troubles in Ecuador.
From partner Eric G. Lasker for The Federalist Society's Engage.
Eric G. Lasker, Firm partner, authors article for the April 2012 Defense Counsel Journal.
Partner Eric G. Lasker authors article for International Association of Defense Counsel Toxics & Hazardous Substances Litigation Committee Newsletter.
Eric Lasker for LJN's Product Liability Law & Strategy newsletter
This industry coalition brief was filed on behalf of the U.S. Chamber of Commerce, American Chemistry Council, American Coatings Association, American Insurance Association, American Petroleum Institute, and National Association of Manufacturers.
Engage: The Journal of the Federalist Society's Practice Groups (February 2009) (Eric G. Lasker)
Eric Lasker for Washington Legal Foundation's Legal Backgrounder
LJN’s Product Liability Law & Strategy (September 2007) (Eric G. Lasker)
Washington Legal Foundation’s Legal Backgrounder (April 13, 2007) (Donald W. Fowler and Eric G. Lasker)
In the final installment, authors Joe Hollingsworth and Eric Lasker, discuss causation opinions premised on clinical practice, and how defense counsel can effectively use Daubert to exclude causation testimony that rests upon anecdotal case reports and clinical reasoning; Michigan Defense Quarterly (April 2007)
Written by Joe Hollingsworth and Eric Lasker, the second article explains how defense counsel can assist courts in properly applying the Daubert requirements to various categories of scientific evidence often cited by plaintiffs' experts in support of general causation opinions. Michigan Defense Quarterly (January 2007).
LJN’s Product Liability Law & Strategy (November 2006) (Eric G. Lasker)
Throwing Out Junk Science: The first article of this 3-part series discusses the legal standards for admissibility of medical causation expert testimony following the Michigan Supreme Court's adoption of the federal Daubert requirements of reliance and relevance. Michigan Defense Quarterly (October 2006) (Joe G. Hollingsworth and Eric G. Lasker).
LJN’s Product Liability Law & Strategy (October 2006) (Eric G. Lasker)
Andrew's Pharmaceutical Litigation Reporter (April 2006) (Eric G. Lasker)
Washington Legal Foundation's Legal Backgrounder (July 15, 2005) (Reprinted in the August 12, 2005, issue of Andrew's Environmental Litigation Reporter (Eric G. Lasker)
Eric Lasker for Washington Legal Foundation's Legal Backgrounder (Reprinted in the May 19, 2005, issue of LexisNexis® Mealey's Emerging Drugs & Devices)
Journal of Health Law (Winter 2004, Volume 37, No. 1) (Joe G. Hollingsworth and Eric G. Lasker)
ABA's Superfund and Natural Resource Damages Litigation Committee Newsletter (December 2003, Volume 1, No. 1, page 12) (Eric G. Lasker)
Mealey's Emerging Drugs & Devices (Vol. 8, #19, October 7, 2003) (Eric G. Lasker)
ABA's The Brief (Winter 2002) (Eric G. Lasker)
Tort & Insurance Law Journal (Volume 37, Number 1, Fall 2001) (Eric G. Lasker)